Medicine Description migrostop 12.5 mg
migrostop 2 tablets 12.5 mg is a medication that works primarily through its action as a selective agonist of the serotonin receptors, particularly the 5-HT1B and 5-HT1D subtypes. When almotriptan binds to these receptors, it causes vasoconstriction of cranial blood vessels, effectively countering the dilation that occurs during a migraine attack. This vasoconstrictive action helps to alleviate headache pain and associated symptoms by reducing the neurogenic inflammation and the release of pro-inflammatory mediators. Additionally, the activation of 5-HT1D receptors leads to a decrease in the release of pro-inflammatory neurotransmitters, further contributing to the relief of migraine symptoms.
Indications and Uses of migrostop 2 tablets 12.5 mg
- Acute treatment of migraine attacks in adults.
- Management of migraine-related symptoms such as nausea and sensitivity to light and sound.
Side Effects of migrostop 2 tablets 12.5 mg
- Dizziness
- Nausea
- Fatigue
- Dry mouth
- Feeling of tightness or pressure in the chest
Storage and Handling
Store at room temperature, away from moisture and heat. Keep the tablets in their original packaging to protect from light.
Patient Advice and Precautions
Before using migrostop, ensure to discuss any pre-existing medical conditions with your healthcare provider. Avoid using this medication in conjunction with other triptans or ergotamine medications. If the headache does not respond to the first dose, do not take a second dose without consulting a healthcare professional. Be aware of potential side effects and report any severe reactions to your doctor immediately.